Clinical Trials Sponsored by Shanghai Changzheng Hospital

Total 3025 results

Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation

Non-Small Cell Lung Cancer | Chinese

China
Shanghai Pulmonary Hospital, Shanghai, China

Active, not recruiting

Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Stage III

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Idiopathic Bronchiectasis and Pulmonary Hypertension

Bronchiectasis | Pulmonary Hypertension

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Corticosteroid Treatment for Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Airway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation

Bronchiectasis Adult

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients (CINSBDRILCP)

Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

NTM-LD Treatment Based on GenSeizer Characteristic Gene Capture Strategy

Non - Tuberculosis Mycobacteria Lung Disease

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis

Bronchiectasis | COPD

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis

Bronchiectasis

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis (VIDB)

Bronchiectasis

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP. (PAP)

Pulmonary Alveolar Proteinosis

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

Stage II-IIIB(N2) Non-small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Robot-assisted vs VATS for Thymoma

Thymoma

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma

EGFR Gene Mutation | Lung Adenocarcinoma Stage III | Lung Adenocarcinoma Stage IV

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial (MAGIC)

Multiple Primary Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Advanced Lung Carcinoma
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients

Small-cell Lung Cancer | Neoadjuvant Therapy

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer

Small-cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation

Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

VATS VS. Open Thoracic Surgery for Stage II - III Lung Cancer (VOLCANO)

Lung Cancer | Surgery

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%

Treatment | Histological Type of Neoplasm | Lung Adenocarcinoma, Stage I | Chemotherapy, Adjuvant

China
Shanghai Pulmonary Hospital, Shanghai, China

Terminated

Neoadjuvant PD-1 Antibody Plus Chemotherapy in Resectable Stage IIIA-N2 Non-Small-Cell Lung Cancer

Non Small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma

EGFR Gene Mutation | Lung Adenocarcinoma Stage III

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Updated Severity and Prognosis Score of Pulmonary Alveolar Proteinosis

Pulmonary Alveolar Proteinosis

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Transthoracic Needle Biopsy Using 3D Printed Navigational Template: A Phase I Feasibility Trial

Lung Neoplasms

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

NGS Combined With RNAseq on Tumor Immune Escape in NSCLC

Non-small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer

Lung Diseases | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Carcinoma, Bronchogenic | Thoracic Surgery | Thoracic Neoplasm

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer

Healthy | Pulmonary Nodule
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

EGFR-TKI With/Without Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

Nonsmall Cell Lung Cancer | EGFR Gene Mutation
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

Non-Small-Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)

Interstitial Lung Diseases

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study

Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

Stage III Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor Environment (NAT-LungMate)

Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for Thymectomy (RATS)

Thymoma | Myasthenia Gravis Associated With Thymoma | Thymectomy

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Lung Adenocarcinoma

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008)

Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Toripalimab Combined With Chemotherapy in Primary Tracheal Squamous Cell Carcinoma

Tracheal Squamous Cell Carcinoma
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Narrow Band Imaging (NBI) Under Electronic Bronchoscope in Lung Cancer

Lung Cancer | Malignant Airway Obstruction

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor

Thymic Epithelial Tumor

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue Fluid (COPandNGS)

Idiopathic Interstitial Pneumonias | Cryptogenic Organizing Pneumonia

China
Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting

Efficacy and Safety of An'Ningpai Expectorant in Non-CF Bronchiectasis

Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Identification of Microbiome and Metabolome of Bronchiectasis in Chinese Population.

Bronchiectasis

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Cytokine Profile of Allergic Bronchopulmonary Aspergillosis

ABPA

China
Shanghai Pulmonary Hospital, Shanghai, China

Active, not recruiting

CX3CR1+T Cell Predict Immunotherapy Efficacy

Non-small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Active, not recruiting

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection

Thoracic Diseases | Thoracic Surgery

China
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis

Bronchiectasis

China

Clinical Trials Sponsored by Shanghai Changzheng Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations